Harbour BioMed logo

Harbour BioMed

Healthy Life · Breakthrough Medicines

VS
Klus Pharma Inc. logo

Klus Pharma Inc.

Discovery and development of novel and safer antibody-based therapeutics.

Side-by-Side Comparison

Metric Harbour BioMed Klus Pharma Inc.
Founded 2016 2014
Headquarters Cambridge, United States Princeton, United States
Employees 113 11
Industry Biopharma, Biotechnology, Pharmaceutical Manufacturing, Pharmaceutical, Marketing
Funding Stage IPO Not tracked yet
Total Funding $533.80M Not tracked yet
Funding Rounds 7 Not tracked yet
Business Model Not tracked yet Not tracked yet
Revenue Model Not tracked yet Not tracked yet
Services Not tracked yet Not tracked yet
Target Customers Not tracked yet Not tracked yet
Taxonomy Biopharmaceutical, Antibody Therapeutics, Oncology, Immunology, Novel Antibody Discovery, Harbour Mice® Platform, Monoclonal Antibodies, Heavy Chain Only Antibodies, Immune Cell Engagers, HBICE® Technology, Transgenic Mouse Platforms, B-cell Cloning, Immuno-oncology, Inflammatory Diseases, Drug Discovery And Development Biologics Drug Discovery And Development, Antibody Discovery, Antibody-drug Conjugates (ADC), Clinical Development, Bispecific Antibodies, Multispecific Antibodies, Immuno-oncology
Website harbourbiomed.com kluspharma.com
Harbour BioMed logo

About Harbour BioMed

Harbour BioMed, operating under the slogan "Healthy Life · Breakthrough Medicines," is a dynamic player in the global biopharmaceutical landscape. Established in 2016, the company has rapidly developed a strong foundation in oncology and immunology through innovative antibody therapeutics. This Uni...

Klus Pharma Inc. logo

About Klus Pharma Inc.

Klus Pharma Inc. is a subsidiary of Kelun Group and affiliated with Kelun-Biotech, focusing on the discovery and development of advanced therapeutic biotechnologies. Established in 2014, the company's primary aim is to address the unmet needs of patients suffering from various severe disorders such...

Frequently Asked Questions

Harbour BioMed — Healthy Life · Breakthrough Medicines. Klus Pharma Inc. — Discovery and development of novel and safer antibody-based therapeutics.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Harbour BioMed has raised $533.80M while Klus Pharma Inc. has raised undisclosed funding.
Harbour BioMed and Klus Pharma Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Track both companies in real time

Signal Tracker monitors Harbour BioMed, Klus Pharma Inc., and millions of companies for 40+ signal types.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy